Product Information
BENZONATATE 100 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0656 per EA under NDC 64980063401. Its NADAC has been published 54 times since Sep 24, 2025.
FDA first approved this application on Jul 31, 2015. Its Orange Book therapeutic-equivalence code is AA.
Strength
100 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980063401
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BENZONATATEApproval Type
Generic (ANDA)
FDA Application
ANDA202765FDA Approved
7/31/2015
TE Code
AA
On Market Since
7/26/2024
Pharmacological Classes
Price Statistics
The NADAC for BENZONATATE 100 MG CAPSULE has been published 54 times since Sep 24, 2025, and over the history we have for it it has declined 8.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0656 per EA |
|---|---|
| All-time high | $0.0732 (Dec 10, 2025) |
| All-time low | $0.0656 (Sep 23, 2026) |
| 52-week high | $0.0732 |
| 52-week low | $0.0656 |
| Median price | $0.0710 |
| Average price | $0.0709 |
| Largest weekly change | -4.6% (Sep 23, 2026) |
| Weeks tracked | 54 |
| Tracking since | Sep 24, 2025 |
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Benzonatate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Non-narcotic Antitussive class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BENZONATATE 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BENZONATATE 100 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $0.0656 per EA (NDC 64980063401), effective Sep 30, 2026.
How has the price of BENZONATATE 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BENZONATATE 100 MG CAPSULE has declined 8.0%. It has been tracked across 54 weekly CMS publications since Sep 24, 2025.
What are the highest and lowest recorded NADAC prices for BENZONATATE 100 MG CAPSULE?
Since Sep 24, 2025, the NADAC for BENZONATATE 100 MG CAPSULE has ranged from a low of $0.0656 (Sep 23, 2026) to a high of $0.0732 (Dec 10, 2025), with a median of $0.0710 per EA.
Are there cheaper alternatives to BENZONATATE 100 MG CAPSULE?
12 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BENZONATATE 100 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures BENZONATATE 100 MG CAPSULE?
BENZONATATE 100 MG CAPSULE (NDC 64980063401) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.